Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 August 2010 - O4 October 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Compliant to GLP and testing guidelines; adequate coherence between data, comments and conclusions.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Details on test material:
- - Name of test material: distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products
- Physical state: yellow liquid
- Purity: not indicated (complex composition)
- Lot/batch No.: LR_OXO_2010-07-12
- Date of analysis: 12 July 2010
- Expiration date of the lot/batch: July 2011
- Storage conditions of test material: at +4°C and under nitrogen gas.
Constituent 1
Method
- Target gene:
- Histidine operon
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- -S9 (both experiments): 312.5, 625, 1250, 2500 and 5000 μg/plate
+S9 (1st experiment): 312.5, 625, 1250, 2500 and 5000 μg/plate
+S9 (2nd experiment): 39.06, 78.13, 156.3, 312.5, 625 and 1250 μg/plate - Vehicle / solvent:
- - Vehicle used: DMSO
- Justification for choice of solvent/vehicle: test item was freely soluble in the vehicle (DMSO) at 100 mg/mL
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: sodium azide, 9-Aminoacridine, 2-Nitrofluorene, Mitomycin C (-S9); 2-Anthramine, Benzo(a)pyrene (+S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar
The test item was tested in a preliminary test and two mutagenicity experiments.
The preliminary test, both experiments without S9 mix and the first experiment with S9 mix were performed according to the direct plate
incorporation method. The second experiment with S9 mix was performed according to the preincubation method.
DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 to 72 hours. - Evaluation criteria:
- A reproducible 2-fold increase (for the TA 98, TA 100 and TA 102 strains) or 3-fold increase (for the TA 1535 and TA 1537 strains) in the number of revertants compared with the vehicle controls, in any strain at any dose-level and/or evidence of a dose-relationship was considered as a
positive result. Reference to historical data, or other considerations of biological relevance may also be taken into account in the evaluation of the data obtained.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- TA 1537 only
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- all but TA 98
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid.
Since the test item was freely soluble and non-toxic, the highest dose-level was 5000 µg/plate, according to the criteria specified in the international guidelines.
Experiments without S9 mix
The selected treatment-levels were: 312.5, 625, 1250, 2500 and 5000 µg/plate for both mutagenicity experiments.
A moderate emulsion was observed in the Petri plates when scoring the revertants at dose-levels >= 2500 µg/plate.
A moderate toxicity was observed at dose-level of 5000 µg/mL in the TA 1537 strain. No noteworthy toxicity was noted towards the other strains used.
The test item did not induce any noteworthy increase in the number of revertants, in any of the five strains.
Experiments with S9 mix
The selected treatment-levels were: 312.5, 625, 1250, 2500 and 5000 µg/plate for the first experiment and 39.06, 78.13, 156.3, 312.5, 625 and 1250 µg/plate for the second experiment.
A moderate emulsion was observed in the Petri plates when scoring the revertants at dose-level of 5000 µg/plate.
A strong toxicity was noted at dose-levels >= 1250 µg/plate in the TA 1537, TA 1535, TA 102 and TA 100 strains. No noteworthy toxicity was noted towards the other strains used.
An slight increase in the number of revertants (up to 2.4-fold the vehicle control value) was noted in the TA 98 strain in the second experiment with S9 mix. This increase exceeded the threshold of 2-fold the vehicle control value, however, it was not dose-related and not observed in the first experiment. Consequently, this increase was considered not to be biologically significant.
The test item did not induce any noteworthy increase in the number of revertants, in any of the other strains. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with/without S9
The test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products, did not show any mutagenic activity in the bacterial reverse mutation test with Salmonella typhimurium. - Executive summary:
The objective of this study was to evaluate the potential of the test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products (batch No. LR_OXO_2010-07-10), to induce reverse mutation in Salmonella typhimurium.
The study was performed according to the international guidelines (OECD 471 and Commission Directive No. B13/14) and in compliance with the principles of Good Laboratory Practice.
Methods
A preliminary toxicity test was performed to define the dose-levels of distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products to be used for the mutagenicity study. The test item was then tested in two independent experiments, with and without a metabolic activation system, the S9 mix, prepared from a liver post‑mitochondrial fraction (S9 fraction) of rats induced with Aroclor 1254.
Both experiments were performed according to the direct plate incorporation method except for the second test with S9 mix, which was performed according to the preincubation method (60 minutes,).
Five strains of bacteria Salmonella typhimurium: TA 1535, TA 1537, TA 98, TA 100 and TA 102 were used. Each strain was exposed to at least five dose-levels of the test item (three plates/dose‑level). After 48 to 72 hours of incubation at, the revertant colonies were scored.
The evaluation of the toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn.
The test item distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products was dissolved in dimethylsulfoxide (DMSO).
The dose-levels of the positive controls were as follows:
without S9 mix
. 1 µg/plate of sodium azide (NaN3): TA 1535 and TA 100 strains,
. 50 µg/plate of 9-Aminoacridine (9AA): TA 1537 strain,
. 0.5 µg/plate of 2-Nitrofluorene (2NF): TA 98 strain,
. 0.5 µg/plate of Mitomycin C (MMC): TA 102 strain.
with S9 mix
. 2 µg/plate of 2-Anthramine (2AM): TA 1535, TA 1537 and TA 98 strains,
. 5 µg/plate of Benzo(a)pyrene (BAP): TA 100 strain,
. 10 µg/plate of 2-Anthramine (2AM): TA 102 strain.
Results
The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid.
Since the test item was freely soluble and non-toxic, the highest dose-level was 5000 µg/plate, according to the criteria specified in the international guidelines.
Experiments without S9 mix
The selected treatment-levels were: 312.5, 625, 1250, 2500 and 5000 µg/plate for both mutagenicity experiments.
A moderate emulsion was observed in the Petri plates when scoring the revertants at dose-levels >= 2500 µg/plate.
A moderate toxicity was observed at dose-level of 5000 µg/mL in the TA 1537 strain. No noteworthy toxicity was noted towards the other strains used.
The test item did not induce any noteworthy increase in the number of revertants, in any of the five strains.
Experiments with S9 mix
The selected treatment-levels were: 312.5, 625, 1250, 2500 and 5000 µg/plate for the first experiment and 39.06, 78.13, 156.3, 312.5, 625 and 1250 µg/plate for the second experiment.
A moderate emulsion was observed in the Petri plates when scoring the revertants at dose-level of 5000 µg/plate.
A strong toxicity was noted at dose-levels >= 1250 µg/plate in the TA 1537, TA 1535, TA 102 and TA 100 strains. No noteworthy toxicity was noted towards the other strains used.
An slight increase in the number of revertants (up to 2.4-fold the vehicle control value) was noted in the TA 98 strain in the second experiment with S9 mix. This increase exceeded the threshold of 2-fold the vehicle control value, however, it was not dose-related and not observed in the first experiment. Consequently, this increase was considered not to be biologically significant.
The test item did not induce any noteworthy increase in the number of revertants, in any of the other strains.
Conclusion
Under our experimental conditions, the test item, distillation residues of butyraldehyde, 2-ethylhexenal and isobutanal hydrogenation by-products
(batch No. LR_OXO_2010-07-10), did not show any mutagenic activity in the bacterial reverse mutation test with Salmonella typhimurium.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Hoewel ECHA veel materiaa in uw taal online heeft, is een deel van deze pagina in het Engels. Meer informatie van ECHA over meertaligheid.
Welkom op de ECHA-website. In Internet Explorer 7 (en vroegere versies) wordt deze site niet volledig ondersteund. U schakelt het best op een recentere versie van Internet Explorer over.
Deze website maakt gebruik van cookies om het surfen zo aangenaam mogelijk te maken.
Lees meer over hoe wij cookies gebruiken.